author-photo

Yoko Miyazaki

Chugai Pharmaceutical Co.

11

Papers

267

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Abstract 2747: Anti-glypican-3 monoclonal antibody (codrituzumab/GC33/RO5137382) treatment enhances tumor infiltration of PD-L1-positive macrophages, and combination therapy with anti-PD-L1 monoclonal antibody promotes antitumor effects

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

2017 Science Translational Medicine
Show All
- Source
- Cite
- Save
Citations (94)
Abstract 3653: Combining ERY974, a novel T cell-redirecting bispecific antibody targeting glypican-3, with chemotherapy profoundly improved antitumor efficacy over its monotherapy in xenograft model

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancer resistance protein-expressing tumor xenografts

2010 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (12)
Abstract 2426: Anti-Glypican3 antibody for treatment of human liver cancer

2010 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Synthesis and biological activities of a pH-dependently activated water-soluble prodrug of a novel hexacyclic camptothecin analog.

2009 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (15)
Development of a new DNA topoisomerase I inhibitor, TP300: A pH-activated water-soluble prodrug

2007 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)